Evaluating colonoscopy quality by performing provider type
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae080 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Emily Berry und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Southwestern Medical Center, Moncrief Cancer Institute, Fort Worth, TX, USA. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, The Cancer Prevention and Research Institute of Texas, NIH HHS.
Abstract (Originalsprache)
Background
Colorectal cancer is the third most diagnosed cancer and the second leading cause of cancer death in the United States. Colonoscopy is an essential tool for screening, used as a primary approach and follow-up to an abnormal stool-based colorectal cancer screening result. Colonoscopy quality is often measured with 4 key indicators: bowel preparation, cecal intubation, mean withdrawal time, and adenoma detection. Colonoscopies are most often performed by gastroenterologists (GI), however, in rural and medically underserved areas, non-GI providers often perform colonoscopies. This study aims to evaluate the quality and safety of screening colonoscopies performed by non-GI practitioner, comparing their outcomes with those of GI providers.
Methods
Descriptive statistics were used to characterize the study population. Results for quality indicators were stratified by provider type and compared. Statistical significance was determined using a P value of less than .05 as the threshold for all comparisons; all P values were 2-sided.
Results
No statistical difference was found when comparing performance by provider type. Median performance for gastroenterologists, general surgeons, and family medicine providers ranged from 98% to 100% for cecal intubation; 97.4% to 100% for bowel preparation; 57.4% to 88.9% for male adenoma detection rate; 47.7% to 62.13% for female adenoma detection rate; and 0:12:10 to 0:20:16 for mean withdrawal time. All provider types met and exceeded the goal metric for each of the quality indicators (P < .001).
Conclusions
As a result of this analysis, we can expect non-GI practitioner to perform colonoscopies with similar quality to GI practitioner given the performance outcomes for the key quality metrics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Texas Southwestern Medical Center, Moncrief Cancer Institute, Fort Worth, TX, USA.
- Department of Family and Community Medicine, University of North Dakota School of Medicine & Health Sciences, Bismark, ND, USA.
- Summit Health, Sisters, OR, USA.
- University of Texas Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.
- University of Texas Medical Center Peter O'Donnell Jr. School of Public Health, Dallas, TX, USA.
ORCID-Profile: Emily Berry, Keith E Argenbright
Förderung
- NCI NIH HHS
- The Cancer Prevention and Research Institute of Texas
- NIH HHS
- National Institutes of Health
Zitieren
APA
Berry, E., Hostetter, J., Bachtold, J., Zamarripa, S., & Argenbright, K. E. (2024). Evaluating colonoscopy quality by performing provider type. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae080
Vancouver
Berry E, Hostetter J, Bachtold J, Zamarripa S, Argenbright KE. Evaluating colonoscopy quality by performing provider type. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae080
BibTeX
@article{Berry2024,
author = {Berry, Emily and Hostetter, Jeff and Bachtold, Joseph and Zamarripa, Sarah and Argenbright, Keith E},
title = {Evaluating colonoscopy quality by performing provider type},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae080}
}
EUVIMED